Portugal (PT)

Enteric nervous system-derived VIP restrains differentiation of LGR5+ stem cells toward the secretory lineage impeding type 2 immune programs (2025) Jakob MO, Sterczyk N, Boulekou S, Forster PM, Barleben L, Alzain N, Jarick KJ, et al. Journal article Could Edible Photonic Structures Be an Alternative to Traditional Food Coloring? (2025) Cerqueira MA, Vogel N, Lopez-Garcia M, Velikov KP, Vignolini S, Pastrana LM Journal article, Note Evidence-based clinical practice guidelines for prevention, screening and treatment of peripartum depression (2025) Radoš SN, Ganho-Ávila A, Rodriguez-Muñoz MF, Bina R, Kittel-Schneider S, Lambregtse-Van den Berg MP, Lega I, et al. Journal article, Review article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article HBM4EU e-waste study – Occupational exposure assessment to chromium, cadmium, mercury and lead during e-waste recycling (2025) Leese E, Verdonck J, Porras SP, Airaksinen J, Duca RC, Galea KS, Godderis L, et al. Journal article Relators and Notions of Simulation Revisited (2025) Goncharov S, Hofmann D, Nora P, Schröder L, Wild P Conference contribution Heat therapy in the treatment of musculoskeletal pain: current pharmacy practice and perspectives (2025) Jaime AG, Ema IGMP, Hotfiel T, Pablo FM, Luis SdM, Karin PD, Ginevra G, Paolo L Journal article Activation mapping in multi-center retrospective rat sensory-evoked functional MRI datasets using a unified pipeline (2025) Galteau ME, Broadwater M, Chen Y, Desrosiers-Gregoire G, Gil R, Käßer J, Kim E, et al. Journal article NFATC2::NUTM2A/B Fusions Characterize a Novel Indolent Myoepithelial-Like Neoplasm of the Lungs and Salivary Glands (2025) Agaimy A, Agaimy A, Dermawan JK, Rios E, Meidenbauer N, Dimmler A, Stöhr R, Antonescu CR Journal article Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease (2025) Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, et al. Journal article